Literature DB >> 9732180

Hepatobiliary diseases in patients with AIDS: focus on AIDS cholangiopathy and gallbladder disease.

C M Wilcox1, K E Mönkemüller.   

Abstract

Diseases of the biliary tree and gallbladder are being described with increasing frequency among patients with the acquired immunodeficiency syndrome (AIDS). Despite the profound immunosuppressive therapy transplant recipients receive, these patients do not appear to be affected by these disorders; thus, human immunodeficiency virus (HIV)-infected patients appear to be uniquely susceptible. Most HIV-infected patients that develop cholangiopathy have severe immunodeficiency with CD4 lymphocyte counts <200/mm3. The objective of this review is to summarize the available literature on AIDS-cholangiopathy, focusing on its diagnosis and classification and to suggest an approach for its evaluation and its management.

Entities:  

Mesh:

Year:  1998        PMID: 9732180     DOI: 10.1159/000016868

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  13 in total

1.  Human intestinal and biliary cryptosporidiosis.

Authors:  Xian-Ming Chen; Nicholas F LaRusso
Journal:  World J Gastroenterol       Date:  1999-10       Impact factor: 5.742

2.  Biliary Problems in People with HIV Disease.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-04

Review 3.  HIV1 and the gut in the era of highly active antiretroviral therapy.

Authors:  Esteban C Nannini; Pablo C Okhuysen
Journal:  Curr Gastroenterol Rep       Date:  2002-10

4.  The human immunodeficiency virus type 1 tat protein enhances Cryptosporidium parvum-induced apoptosis in cholangiocytes via a Fas ligand-dependent mechanism.

Authors:  Steven P O'Hara; Aaron J Small; Jeremy B Nelson; Andrew D Badley; Xian-Ming Chen; Gregory J Gores; Nicholas F Larusso
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

5.  Disseminated tuberculosis manifesting as cholestasis in a patient with AIDS: a presentation to remember.

Authors:  Theresa May Lee; Sheela V Shenoi; Onyema Ogbuagu
Journal:  BMJ Case Rep       Date:  2014-02-23

Review 6.  Challenges in understanding the immunopathogenesis of Cryptosporidium infections in humans.

Authors:  R J Kothavade
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-12       Impact factor: 3.267

Review 7.  Biliary Strictures: Etiologies and Medical Management.

Authors:  Terrance Rodrigues; Justin R Boike
Journal:  Semin Intervent Radiol       Date:  2021-08-10       Impact factor: 1.780

8.  HIV-1 Tat protein suppresses cholangiocyte toll-like receptor 4 expression and defense against Cryptosporidium parvum.

Authors:  Steven P O'Hara; Aaron J Small; Gabriella B Gajdos; Andrew D Badley; Xian-Ming Chen; Nicholas F Larusso
Journal:  J Infect Dis       Date:  2009-04-15       Impact factor: 5.226

Review 9.  Sclerosing Cholangitis: Clinicopathologic Features, Imaging Spectrum, and Systemic Approach to Differential Diagnosis.

Authors:  Nieun Seo; So Yeon Kim; Seung Soo Lee; Jae Ho Byun; Jin Hee Kim; Hyoung Jung Kim; Moon-Gyu Lee
Journal:  Korean J Radiol       Date:  2016-01-06       Impact factor: 3.500

10.  AIDS Cholangiopathy in an Asymptomatic, Previously Undiagnosed Late-Stage HIV-Positive Patient from Kenya.

Authors:  Yiming Gao; Kathryn Chin; Yehia Y Mishriki
Journal:  Int J Hepatol       Date:  2011-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.